21 related articles for article (PubMed ID: 27146520)
1. Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery.
Varan G; Benito JM; Mellet CO; Bilensoy E
Beilstein J Nanotechnol; 2017; 8():1457-1468. PubMed ID: 28900599
[No Abstract] [Full Text] [Related]
2. Top-down and bottom-up approaches in production of aqueous nanocolloids of low solubility drug paclitaxel.
Pattekari P; Zheng Z; Zhang X; Levchenko T; Torchilin V; Lvov Y
Phys Chem Chem Phys; 2011 May; 13(19):9014-9. PubMed ID: 21442095
[TBL] [Abstract][Full Text] [Related]
3. Cellular Interaction and Tumoral Penetration Properties of Cyclodextrin Nanoparticles on 3D Breast Tumor Model.
Varan G; Patrulea V; Borchard G; Bilensoy E
Nanomaterials (Basel); 2018 Jan; 8(2):. PubMed ID: 29373490
[TBL] [Abstract][Full Text] [Related]
4. A Promising Review on Cyclodextrin Conjugated Paclitaxel Nanoparticles for Cancer Treatment.
Velhal K; Barage S; Roy A; Lakkakula J; Yamgar R; Alqahtani MS; Yadav KK; Ahn Y; Jeon BH
Polymers (Basel); 2022 Aug; 14(15):. PubMed ID: 35956677
[TBL] [Abstract][Full Text] [Related]
5. Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics.
Gadade DD; Pekamwar SS
Adv Pharm Bull; 2020 Jun; 10(2):166-183. PubMed ID: 32373486
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of β-Sitosterol Loaded PLGA and PEG-PLA Nanoparticles for Effective Treatment of Breast Cancer: Preparation, Physicochemical Characterization, and Antitumor Activity.
Andima M; Costabile G; Isert L; Ndakala AJ; Derese S; Merkel OM
Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30445705
[TBL] [Abstract][Full Text] [Related]
7. Development of Houttuynia cordata Extract-Loaded Solid Lipid Nanoparticles for Oral Delivery: High Drug Loading Efficiency and Controlled Release.
Kim JH; Baek JS; Park JK; Lee BJ; Kim MS; Hwang SJ; Lee JY; Cho CW
Molecules; 2017 Dec; 22(12):. PubMed ID: 29236057
[No Abstract] [Full Text] [Related]
8. Stability of paclitaxel-loaded solid lipid nanoparticles in the presence of 2-hydoxypropyl-β-cyclodextrin.
Baek JS; Kim BS; Puri A; Kumar K; Cho CW
Arch Pharm Res; 2016 Jun; 39(6):785-93. PubMed ID: 27146520
[TBL] [Abstract][Full Text] [Related]
9. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
Baek JS; Cho CW
J Pharm Pharmacol; 2013 Jan; 65(1):72-8. PubMed ID: 23215690
[TBL] [Abstract][Full Text] [Related]
10. Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection.
Baek JS; Kim JH; Park JS; Cho CW
Int J Nanomedicine; 2015; 10():5397-405. PubMed ID: 26347363
[TBL] [Abstract][Full Text] [Related]
11. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
Baek JS; Cho CW
Int J Pharm; 2015 Jan; 478(2):617-24. PubMed ID: 25510604
[TBL] [Abstract][Full Text] [Related]
12. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
13. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
